NASDAQ: IGMS
Igm Biosciences Inc Earnings Dates, Reports, Calls

Igm Biosciences earnings were -$198.9M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest IGMS earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$52.9M, up 44.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IGMS reported annual earnings of -$195.8M, with -20.5% growth.

IGMS earnings history

Current Revenue
$2.7M
Current Earnings
-$198.9M
Current Profit Margin
-7,417.8%

IGMS Return on Equity

Current Company
-318%
Current Industry
-60.2%
Current Market
31.5%
IGMS's Return on Equity (-318%)... subscribe to Premium to read more.
High Return on Equity Performance

IGMS undefined

Current Company
-71.4%
Current Industry
-2.5%
IGMS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IGMS announces earnings.

IGMS undefined

Current Company
-111.29%
Current Industry
5.8%
IGMS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IGMS vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IGMS-$184.68M-$198.87MN/A-$3.27
INO-$93.37M-$96.48MN/A-$3.19
EPIX-$28.40M-$28.50MN/A-$0.63
ZURA-$62.08M-$62.10MN/A-$0.70
DOMH-$41.30M-$41.75MN/A-$4.51

Igm Biosciences Earnings Reports & History FAQ

What were Igm Biosciences's earnings last quarter?

On IGMS's earnings call on Invalid Date, Igm Biosciences (NASDAQ: IGMS) reported Q1 2025 earnings per share (EPS) of -$0.86, up 3.61% year over year. Total IGMS earnings for the quarter were -$52.89 million. In the same quarter last year, Igm Biosciences's earnings per share (EPS) was -$0.83.

If you're new to stock investing, here's how to buy Igm Biosciences stock.

Is Igm Biosciences profitable or losing money?

As of the last Igm Biosciences earnings report, Igm Biosciences is currently losing money. Igm Biosciences's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$198.87 million, a 16.06% decrease year over year.

What was IGMS's earnings growth in the past year?

As of Igm Biosciences's earnings date in Invalid Date, Igm Biosciences's earnings has grown year over year. IGMS earnings in the past year totalled -$198.87 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.